-
1
-
-
0026511161
-
Prevalence of amplification of the oncogenes c-myc, HER-2/neu, and int-2in one thousand human breast tumors: Correlation with steroid receptors
-
[doi:10.1016/S0959-8049(05)80129-7]
-
Berns, E.M.J.J., Klijn, J.G.M., van Staveren, I.L., Portengen, H., Noordegraaf, E., Foekens, J.A., 1992. Prevalence of amplification of the oncogenes c-myc, HER-2/neu, and int-2in one thousand human breast tumors: Correlation with steroid receptors. Eur. J. Cancer, 28(2-3):697-700. [doi:10.1016/S0959-8049(05)80129-7]
-
(1992)
Eur. J. Cancer
, vol.28
, Issue.2-3
, pp. 697-700
-
-
Berns, E.M.J.J.1
Klijn, J.G.M.2
van Staveren, I.L.3
Portengen, H.4
Noordegraaf, E.5
Foekens, J.A.6
-
2
-
-
0000880764
-
Quantitation of EGFR and c-erbB-2 expression in pre-invasive compared to invasive breast cancer
-
[doi:10.1016/S0959-8049(99)81219-2]
-
Chong, D., Cooke, T.G., Reeves, J.R., 1999. Quantitation of EGFR and c-erbB-2 expression in pre-invasive compared to invasive breast cancer. Eur. J. Cancer, 35(Suppl. 4):S203. [doi:10.1016/S0959-8049(99)81219-2]
-
(1999)
Eur. J. Cancer
, vol.35
, Issue.SUPPL. 4
-
-
Chong, D.1
Cooke, T.G.2
Reeves, J.R.3
-
3
-
-
0023663896
-
Over-expression of the human EGF receptor confers an EDF-dependent transformed phenotype to NIH 3T3 cells
-
[doi:10.1016/0092-8674(87)90592-7]
-
Di Fiore, P.P., Pierce, J.H., Fleming, T.P., Hazan, R., Ullrich, A., King, C.R., Schlessinger, J., Aaronson, S.A., 1987. Over-expression of the human EGF receptor confers an EDF-dependent transformed phenotype to NIH 3T3 cells. Cell, 51(6):1063-1070. [doi:10.1016/0092-8674(87)90592-7]
-
(1987)
Cell
, vol.51
, Issue.6
, pp. 1063-1070
-
-
Di Fiore, P.P.1
Pierce, J.H.2
Fleming, T.P.3
Hazan, R.4
Ullrich, A.5
King, C.R.6
Schlessinger, J.7
Aaronson, S.A.8
-
4
-
-
33846184974
-
HER2/neu role in breast cancer: From a prognostic foe to a predictive friend
-
Ferretti, G., Felici, A., Papaldo, P., Fabi, A., Cognetti, F., 2007. HER2/neu role in breast cancer: From a prognostic foe to a predictive friend. Curr. Opin. Obstet. Gynecol., 19(1):56-62.
-
(2007)
Curr. Opin. Obstet. Gynecol.
, vol.19
, Issue.1
, pp. 56-62
-
-
Ferretti, G.1
Felici, A.2
Papaldo, P.3
Fabi, A.4
Cognetti, F.5
-
5
-
-
35248895346
-
HER2 and response to paclitaxel in node-positive breast cancer
-
[doi:10.1056/NEJMoa071167]
-
Hayes, D.F., Thor, A.D., Dressler, L.G., Weaver, D., Edgerton, S., Cowan, D., Broadwater, G., Goldstein, L.J., Martino, S., Ingle, J.N., et al., 2007. HER2 and response to paclitaxel in node-positive breast cancer. N. Engl. J. Med., 357(15):1496-1506. [doi:10.1056/NEJMoa071167]
-
(2007)
N. Engl. J. Med.
, vol.357
, Issue.15
, pp. 1496-1506
-
-
Hayes, D.F.1
Thor, A.D.2
Dressler, L.G.3
Weaver, D.4
Edgerton, S.5
Cowan, D.6
Broadwater, G.7
Goldstein, L.J.8
Martino, S.9
Ingle, J.N.10
-
6
-
-
33748977881
-
Controversies in the assessment of HER-2: More questions than answers
-
[doi:10.1097/01.pap.0000213043.16200.92]
-
Leong, T.Y., Leong, A.S., 2006. Controversies in the assessment of HER-2: More questions than answers. Adv. Anat. Pathol., 13(5):263-269. [doi:10.1097/01.pap.0000213043.16200.92]
-
(2006)
Adv. Anat. Pathol.
, vol.13
, Issue.5
, pp. 263-269
-
-
Leong, T.Y.1
Leong, A.S.2
-
7
-
-
33646681444
-
HER2 and responsiveness of breast cancer to adjuvant chemotherapy
-
[doi:10.1056/NEJMoa054504]
-
Pritchard, K.I., Shepherd, L.E., O'Malley, F.P., Andrulis, I.L., Tu, D., Bramwell, V.H., Levine, M.N., 2006. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N. Engl. J. Med., 354(20):2103-2111. [doi:10.1056/NEJMoa054504]
-
(2006)
N. Engl. J. Med.
, vol.354
, Issue.20
, pp. 2103-2111
-
-
Pritchard, K.I.1
Shepherd, L.E.2
O'Malley, F.P.3
Andrulis, I.L.4
Tu, D.5
Bramwell, V.H.6
Levine, M.N.7
-
8
-
-
37849046940
-
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis
-
(Epub ahead of print). [doi:10.1093/annonc/mdm431]
-
Révillion, F., Lhotellier, V., Hornez, L., Bonneterre, J., Peyrat, J.P., 2007. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann. Oncol., (Epub ahead of print). [doi:10.1093/annonc/ mdm431]
-
(2007)
Ann. Oncol.
-
-
Révillion, F.1
Lhotellier, V.2
Hornez, L.3
Bonneterre, J.4
Peyrat, J.P.5
-
9
-
-
41149139631
-
-
Shanghai Science and Technology Publishing Company, China, (in Chinese)
-
Shen, Z.Z., Shao, Z.M., 2002. Development of Modern Breast Cancer Oncology. Shanghai Science and Technology Publishing Company, China, p. 128-129 (in Chinese).
-
(2002)
Development of Modern Breast Cancer Oncology
, pp. 128-129
-
-
Shen, Z.Z.1
Shao, Z.M.2
-
10
-
-
33749595041
-
Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray
-
[doi:10.1177/1066896906293055]
-
Shin, S.J., Hyjek, E., Early, E., Knowles, D.M., 2006. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray. Int. J. Surg. Pathol., 14(4):279-284. [doi:10.1177/1066896906293055]
-
(2006)
Int. J. Surg. Pathol.
, vol.14
, Issue.4
, pp. 279-284
-
-
Shin, S.J.1
Hyjek, E.2
Early, E.3
Knowles, D.M.4
|